NCT00241046View on ClinicalTrials.gov

Letrozole in the Treatment of 1st and 2nd Line Hormone Receptor Positive Breast Cancer: Pre-therapeutic Risk Assessment

PHASE4TerminatedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

March 31, 2005

Conditions
Metastatic Breast Cancer
Interventions
DRUG

Letrozole

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY